saprophyticus was resistance to the second and third generation cephalosporin (cefuroxim: 30.3%, ceftriaxon: 43.2% and ceftazidim: 66.7%), sulfamethoxazole / trimethoprim (69%) and quinolon (resistance to levofloxacin, ofloxacin and ciprofloxacin were 43.5%, 59.3% and 58.1%, respectively), sensitive to the β-lactam / β-lactamase inhibitor combinations, imipenem (90%) and meropenem (95.7%).